BRCA2 and carcinoma: We and others have recently shown that carcinomas from patients with inherited frameshift mutations in BRCA1 or BRCA2 exposed to chemotherapy can acquire secondary mutations that restore the reading frame of BRCA1 or BRCA2, resulting in platinum resistance [11-13].